Mark Wormke
Impact in
-
- Effects and risks of endocrine disrupting chemicals
- Toxic Organic Pollutants Impact
- Genetics top 2%
- Estrogen and related hormone effects
Papers in
-
- Toxic Organic Pollutants Impact 8
- Effects and risks of endocrine disrupting chemicals 7
- Genetics 13
- Estrogen and related hormone effects 13
- Co-authors
- Stephen SafeMatthew StonerRobert C. BurghardtBrad SavilleIsmael SamudioMaen AbdelrahimThu Annelise NguyenChunhua Qin
- Journals
- Journal of Biological Chemistry (4 papers)Archives of Biochemistry and Biophysics (2 papers)Molecular Endocrinology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesSwedenItaly
In The Last Decade
Mark Wormke
19 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 100
- Health, Toxicology and Mutagenesis 656
- Genetics 890
- Cancer Research 426
- Physiology 85
- Toxicology 63
Countries citing papers authored by Mark Wormke
This map shows the geographic impact of Mark Wormke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wormke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wormke more than expected).
Fields of papers citing papers by Mark Wormke
This network shows the impact of papers produced by Mark Wormke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wormke. The network helps show where Mark Wormke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Wormke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A comparative bioequivalence study of two prolonged-release metoprolol preparations | 2012 | 1 |
| 2 | 2007 | 35 | |
| 3 | 2003 | 117 | |
| 4 | Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. | 2003 | 152 |
| 5 | 2003 | 276 | |
| 6 | 2003 | 255 | |
| 7 | 2002 | 38 | |
| 8 | 2002 | 85 | |
| 9 | Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. | 2001 | 54 |
| 10 | 2000 | 329 | |
| 11 | 2000 | 140 | |
| 12 | 2000 | 72 | |
| 13 | 2000 | 71 | |
| 14 | 2000 | 91 | |
| 15 | 1999 | 31 | |
| 16 | 1997 | 19 | |
| 17 | 1997 | 33 | |
| 18 | 1994 | 105 | |
| 19 | 1994 | 46 |
About Mark Wormke
Mark Wormke is a scholar working on Health, Toxicology and Mutagenesis, Genetics, Cancer Research, Molecular Biology and Statistics and Probability, having authored 19 papers that have together received 1.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (13 papers), Toxic Organic Pollutants Impact (8 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Retinoids in leukemia and cellular processes (6 papers), Carcinogens and Genotoxicity Assessment (2 papers), Inflammatory mediators and NSAID effects (2 papers), 14-3-3 protein interactions (2 papers) and Garlic and Onion Studies (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (656 citations), Genetics (890 citations), Cancer Research (426 citations), Physiology (85 citations) and Toxicology (63 citations). Mark Wormke has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Stephen Safe, Matthew Stoner, Robert C. Burghardt, Brad Saville, Ismael Samudio, Maen Abdelrahim, Thu Annelise Nguyen, Chunhua Qin, Jan-Ακε Gustafsson and Fan Wang. Their work appears in journals such as Journal of Biological Chemistry, Archives of Biochemistry and Biophysics, Molecular Endocrinology, JNCI Journal of the National Cancer Institute and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.